EQL Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is April - March.

Millions SEK. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	86.76	82.4	20.47	44.43	41.2
Cash & Short-Term Investments	86.76	82.4	20.47	44.43	41.2
Cash Growth	5.29%	302.58%	-53.93%	7.83%	55.01%
Accounts Receivable	92.74	125.68	58.34	51.7	34.1
Other Receivables	23.84	0.15	2.74	0	3.5
Total Trade Receivables	116.58	125.84	61.08	51.7	37.6
Inventory	200.53	179.03	105.63	65.37	41.67
Other Current Assets	-	12.99	10.6	5.73	2.98
Total Current Assets	403.87	400.25	197.77	167.23	123.45
Net Property, Plant & Equipment	5.9	12.65	5.35	4.24	8.38
Other Intangible Assets	441.11	402.25	173.31	115.32	110.24
Long-Term Investments	0	0	0	0	0
Total Assets	850.89	808.82	373.76	285.7	237.89
Accounts Payable	70.26	90.94	49.83	29.61	15.98
Accrued Expenses	-	5.08	4.14	16.07	15.29
Short-Term Debt	103.23	107.41	102.22	63.7	59.32
Current Portion of Long-Term Debt	-	4.11	0	-	5.4
Current Portion of Leases	-	2.75	1.4	1.21	-
Other Current Liabilities	36.75	10.73	4.46	6.6	2.78
Total Current Liabilities	210.23	221.02	162.05	117.19	98.76
Long-Term Debt	345.17	338.39	15.45	0	7.2
Long-Term Leases	-	3.05	1.02	1.71	4.19
Other Long-Term Liabilities	28.43	25.34	17.51	12.05	4.12
Total Long-Term Liabilities	373.6	366.77	33.98	13.76	15.51
Total Liabilities	583.83	587.79	196.03	130.94	114.26
Common Stock	-	1.31	1.31	1.31	1.31
Additional Paid-in Capital	-	67.64	67.45	67.18	66.99
Retained Earnings	-	152.08	108.97	86.26	55.33
Total Common Shareholders' Equity	267.06	221.03	177.73	154.75	123.63
Shareholders' Equity	267.06	221.03	177.73	154.75	123.63
Total Liabilities & Equity	850.89	808.82	373.76	285.7	237.89
Total Debt	448.4	455.71	120.09	66.62	76.1
Net Cash (Debt)	-361.64	-373.31	-99.63	-22.19	-34.9
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-11.99	-12.49	-3.34	-0.75	-1.18
Book Value	267.06	221.03	177.73	154.75	123.63
Book Value Per Share	8.85	7.39	5.96	5.24	4.18
Tangible Book Value	-174.06	-181.21	4.42	39.43	13.38
Tangible Book Value Per Share	-5.77	-6.06	0.15	1.34	0.45